// App-Quantinova.ai

P183 : Disease activity, comorbidities and functional status predict treatment response to biologic and targeted synthetic disease-modifying anti-rheumatic drugs in psoriatic arthritis

Researchers

Presenter

  • Christine Addae-Kyereme

Principal Investigators

  • Stephanie Lembke

  • Gary J Macfarlane

  • Gareth T Jones

Medical Centers

  • Epidemiology Group, Aberdeen Centre for Arthritis and Musculoskeletal Health, The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom

  • Aberdeen Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, Aberdeen, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved